Peng Deng1, Xiahong Wang2, Jingjing Sui3, Jianyue Pang1, Qian Liu1, Hengfen Li1. 1. Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China. E-mail: lihengfen8106@126.com. 2. Department of Neurology, The Second People's Hospital of Zhengzhou, Zhengzhou, P. R. China. 3. Department of Psychiatry, Tianjin Anding Hospital, Tianjin, P. R. China.
Sir,Modified electroconvulsive therapy (mECT) is an effective treatment for schizophrenia, which has a few complications, including delayed suffocation and severe arrhythmia.[1] There has been little information about convulsive status epilepticus (nonconvulsive status epilepticus [NCSE]) and central paralysis induced by mECT.A 31-year-old woman had been diagnosed with schizophrenia at the age of 18 years. Generalized tonic-clonic seizures occurred while she was once under treatment with clozapine (100 mg/day), whereby electroencephalogram (EEG) examinations revealed that spike-slow complex waves were located in the right hemisphere [Figure 1].
Figure 1
The first time of electroencephalogram showed 1 Hz spike-slow complex waves on her right hemisphere
The first time of electroencephalogram showed 1 Hz spike-slow complex waves on her right hemisphereShe was admitted to the hospital because of a relapse of schizophrenia and was treated with mECT. A series of symptoms occurred within 1 h after the 6th time mECT, including loss of consciousness, intermittent trembling, muscular twitching in half of her face, limb stiffness, and incontinence. Tonic-clonic seizures occurred abruptly after 2 weeks. Her consciousness recovered after 8-week treatment of magnesium valproate (500 mg/day).She underwent mECT again without complete withdrawal of magnesium valproate after 16 days. After the 7th time mECT, loss of consciousness, intermittent eye gaze, and limb twitching occurred. At that time, the EEG showed increased β-waves. Magnetic resonance imaging showed brain atrophy. She regained consciousness after 4-week treatments of magnesium valproate (750 mg/day) and levetiracetam (500 mg/day). She remained with unclear articulation and muscle hypertonia of the four limbs. Moreover, she could neither hold things nor walk.Magnesium valproate (500 mg/day) was used continuously with withdrawal of levetiracetam gradually. After 2 years of functional training, her communication was established. Coordinated movement of the upper limbs returned to normal. Muscle tension of the lower limbs was still elevated in the absence of muscular dystrophy of four limbs. She could walk with the help of others.These results supported the diagnosis of central paralysis as follows: impaired consciousness, muscle hypertonia of the four limbs, catalepsy, unclear articulation, and brain atrophy on brain magnetic resonance imaging. In addition, the paralysis lasted almost 2 years without muscular dystrophy. Motor function of the four limbs recovered from the upper to the lower limbs. Central paralysis, also called motor neuron palsy, is caused by damage to the cortical motor area and the central pathway (corticospinal tract and cortex–brainstem tract). Since the fibers and cells constituting a fiber bundle in these areas are arranged quite closely, motor neuron paralysis is extensive; it affects the whole body or one side of the body.[23]Moreover, the lack of reasonable recognition of NCSE causing central paralysis was highly suspected. The definition of NCSE often involves a history of preexisting epilepsy and response to treatment.[4] Furthermore, the features of NCSE are different degrees of impaired consciousness lasting for several weeks or months, myoclonias, catalepsy, mutism, seizures, minor facial twitching, and subtle limb jerks.[456] In this case, mutism and intermittent facial and limb twitches appeared. Unconsciousness continued for several weeks. These were consistent with clinical manifestations described above.In NCSE, electroencephalographic changes are important. However, only increased β-waves were captured in this case, probably because of treatment with magnesium valproate, which mainly reduces the frequency of interictal discharge and shows no significant effect on the discharge duration, as well as the initiation site and propagation speed.[7]
Financial support and sponsorship
This study was funded by grants from the National Natural Science Foundation of China (81371494).